TrialEpilepsia open2025

Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW).

Giorgia Giussani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.